
Introduction to IBD Trials.
Global Impact of IBD.
What is Inflammatory Bowel Disease (IBD)?
Overview of current IBD treatments—aminosalicylates, corticosteroids, immune modulators, and biologics—with risks and administration methods. Also covers lifestyle, supplement interactions, personalized medicine, and challenges and failure rates in trials.
Identify key barriers in IBD trials: a 50–70% screen-failure rate from unpredictable disease and washouts, and the reliance on invasive endoscopies that hinder recruitment.
Evaluate trial design and post-trial barriers in inflammatory bowel disease, weighing placebo ethics, endoscopy-based eligibility, patient hardship, and strategies for ongoing access after trials.
Address research gaps in IBD trials and safety concerns. Highlight sex-based genetic differences, cancer risks, and cardiac issues to guide a framework improving trial safety and efficacy.
Present the holistic IBD clinical innovation framework with six classes and 19 pillars, advancing holistic patient care, cardiovascular and cancer risk assessments, informed consent and trial awareness, and personalized trials.
Modernize IBD trials by simplifying medical information with visual aids and promoting shared decision making. Enhance patient navigators, comprehensive support, and physician training to improve protocol adherence and satisfaction.
Expand inclusion criteria for IBD trials and reduce invasiveness by adopting noninvasive monitoring, holistic pre-screening, and geriatric-inclusive designs to improve recruitment, retention, and representativeness.
This course aims to provide an in-depth understanding of the unique challenges faced in IBD clinical research and present a comprehensive framework to address and overcome these challenges. It is designed for clinical researchers, healthcare professionals, and students in the clinical research field.
Learn the framework you can use to address the challenges we see in IBD Clinical Research. This course aims to provide you with a simplified overview of IBD clinical research framework using simplified explanations, clear diagrams, and use cases.
We will be covering the following topics in this course:
Foundations of IBD
Crohn’s Disease
Ulcerative Colitis
Current Global State of IBD
Types of IBD Treatments Available Today
Challenges in IBD Clinical Trials
Enrollment Hurdles
Age and Gender Biases
Ethical Dilemmas and Methodological Shifts
Participant Hardships and Post-Trial Concerns
Research Gaps
Framework
This is the first version of this course and it will be updated as we continue to witness breakthroughs in the field of IBD clinical trials. My aim is to make this knowledge accessible to a global audience, empowering learners to understand and apply modern frameworks that address challenges in clinical trials throughout their professional journey.
You will benefit from this course if:
You want to understand the challenges we face in IBD Clinical Trials
You want to learn the foundations of IBD Clinical Research
You have a genuine interest in understanding a framework you can explore to address these challenges in IBD Trials
Hope you will enjoy this course!